<abstract xmlns="http://www.w3.org/1999/xhtml">

The development and implementation of new and safe means of treating subclinical mastitis (SM) in the production process remains a pressing problem. Our study aimed to investigate the therapeutic effect of the <italic>Bacillus megaterium</italic> NCH 55 strain on cow SM. All animals with signs of SM were fed with a basic diet with probiotic’s addition of 15 g/per day. The experiment was conveyed in 30 consecutive days. Milk and blood were collected on the 7th, 15th, and 30th day of the experiment. Daily milk yield was increased by 32.2% and somatic cell count was decreased from 290.00±32.12 to 96.80±39.03 ths/cm3. A decrease in inflammation was indicated by a decrease in POM370 (by 2.2 times) and POM430 (by 2.8 times). No significant changes in the blood serum indices of cows were observed. A probiotic’s positive effect has been established on the treatment of SM. The probiotic <italic>B. megaterium</italic> NСH 55 can be considered as an alternative to antibiotics and other chemotherapeutic drugs for treating SM in cows.
</abstract>

The development and implementation of new and safe means of treating subclinical mastitis (SM) in the production process remains a pressing problem. Our study aimed to investigate the therapeutic effect of the Bacillus megaterium NCH 55 strain on cow SM. All animals with signs of SM were fed with a basic diet with probiotic’s addition of 15 g/per day. The experiment was conveyed in 30 consecutive days. Milk and blood were collected on the 7th, 15th, and 30th day of the experiment. Daily milk yield was increased by 32.2% and somatic cell count was decreased from 290.00±32.12 to 96.80±39.03 ths/cm3. A decrease in inflammation was indicated by a decrease in POM370 (by 2.2 times) and POM430 (by 2.8 times). No significant changes in the blood serum indices of cows were observed. A probiotic’s positive effect has been established on the treatment of SM. The probiotic B. megaterium NСH 55 can be considered as an alternative to antibiotics and other chemotherapeutic drugs for treating SM in cows.

Use of Probiotic <italic>Bacillus megaterium</italic> NCH 55 for Treatment of Subclinical Mastitis in Cows – Preliminary Study

Department of Obstetrics and Surgery, Faculty of Veterinary Medicine

Department of Public Health, Medical Institute

Department of Biostructure and Animal Physiology, Faculty of Veterinary Medicine

Wroclaw University of Environmental and Life Sciences

Department of Therapy, Pharmacology, Clinical Diagnostics and Chemistry, Faculty of Veterinary Medicine

Macedonian Veterinary Review

This work is licensed under the Creative Commons Attribution 4.0 International License.

Use of Probiotic  NCH 55 for Treatment of Subclinical Mastitis in Cows – Preliminary Study

The development and implementation of new and safe means of treating subclinical mastitis (SM) in the production process remains a pressing problem. Our study...

Use of Probiotic Bacillus megaterium NCH 55 for Treatment of Subclinical Mastitis in Cows – Preliminary Study

Publié en ligne: 23 nov. 2022

Pages: 209 - 214

Reçu: 17 nov. 2021

Accepté: 29 juil. 2022

DOI: https://doi.org/10.2478/macvetrev-2022-0023

Mots clés
cow, mastitis, milk, probiotics,

© 2022 Oksana Shkromada et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Use of Probiotic Bacillus megaterium NCH 55 for Treatment of Subclinical Mastitis in Cows – Preliminary Study

Publié en ligne: 23 nov. 2022

Pages: 209 - 214

Reçu: 17 nov. 2021

Accepté: 29 juil. 2022

DOI: https://doi.org/10.2478/macvetrev-2022-0023

Mots cléscow, mastitis, milk, probiotics,

© 2022 Oksana Shkromada et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.

Mots clés
cow, mastitis, milk, probiotics,